Riskpilot← Back to searchSign inGet full accessVETLABS AS
ASActiveOrg 919191260Hyllveien 19, 0274 OsloSupport activities for fishing and aquaculture · NACE 0330Est. 20172 employees
Revenue 2024
NOK 5,7M
-7% vs 2023
EBITDA margin
18.2%
-21% vs 2023
Equity ratio
19.1%
Financial strength
Net profit 2024
NOK 646K
-29% vs 2023
| Revenue | NOK 5,7M | -7% |
| EBITDA | NOK 1M | -21% |
| Net profit | NOK 646K | -29% |
| Total assets | NOK 2,6M | +8% |
| Equity | NOK 503K | -14% |
| Employees | 2 | — |
Legal name
VETLABS AS
Org number
919191260
Legal form
Aksjeselskap
NACE code
0330 · Support activities for fishing and aquaculture
Founded
24. juni 2017
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Konsulenttjenester rettet mot aquanæringen, herunder konsulenttjenester knyttet til forskning, samt øvrig konsulenttjenester knyttet til dyr, og annen virksomhet som har naturlig tilknytning til noen av disse.
Address
Hyllveien 19, 0274 Oslo
Phone
+4793039930
Email
jo@vetlabs.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 351 | 3 186 | 3 529 | 6 159 | 5 711 |
| Staff expenses | −352 | −1 061 | −629 | −1 079 | −717 |
| EBITDA | −372 | 328 | 440 | 1 317 | 1 042 |
| Depreciation & amort. | −0 | −169 | −254 | −178 | −112 |
| EBIT | −372 | 159 | 186 | 1 139 | 930 |
| Net financials | 0 | −15 | −21 | −32 | −27 |
| Profit before tax | −372 | 145 | 165 | 1 106 | 903 |
| Tax | −42 | −0 | −0 | 191 | 257 |
| Net profit | −330 | 145 | 165 | 915 | 646 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 451 | 1 504 | 1 397 | 2 440 | 2 635 |
| Equity | −67 | 78 | 243 | 583 | 503 |
| Long-term debt | 0 | 441 | 345 | 316 | 311 |
| Short-term debt | 518 | 985 | 808 | 1 542 | 1 820 |
| Total debt | 518 | 1 426 | 1 153 | 1 857 | 2 132 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20202024
Equity ratio
19.1%
This company
38.2%
Market median
-50% vs market
20202024
Return on equity
128.4%
This company
18.4%
Market median
+598% vs market
20202024
Net profit margin
11.3%
This company
8.1%
Market median
+40% vs market
20202024
Asset turnover
2.17×
This company
1.12×
Market median
+94% vs market
20202024
Debt / equity
4.24×
This company
0.62×
Market median
-584% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Amundstad Invest As
VETLABS AS Board members of VETLABS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jo Oeding Amundstad | Chairman | 0 companies |